Trial site
Azienda Ospedaliera Santobono Pausilipon
Naples, 80123, ItalyNot linked to an institution yet
- 21running trials
- 1closed trial
The trials here
What the 24 trials at this site are about, from their registry records.
- Phase
- Phase 39 trials
- Phase 26 trials
- Phase 1/25 trials
- Phase 2/33 trials
- Status
- Recruiting12 trials
- Not yet recruiting5 trials
- Active, not recruiting4 trials
- Suspended2 trials
- Completed1 trial
- Lead sponsor
- Amgen2 trials
- Associazione Italiana Ematologia Oncologia Pediatrica2 trials
- Charite University, Berlin, Germany2 trials
- GPOH gGmbH2 trials
- The University Of Birmingham2 trials
- and 14 more
Running trials
Recruiting
International Study for Treatment of Childhood Relapsed Precursor B-Cell ALL 2020 (IntReALL BCP 2020)
NCT07476729· Phase 3· Charite University, Berlin, Germany· Source
Recruiting
Revumenib Treatment in Combination with FLA Chemotherapy in Paediatric Refractory/Relapsed KMT2A-r, NUP98-r or NPM1-mut Acute Myeloid Leukemia (AML)
2025-521390-14-00· Phase 2· Pediatric Research International GmbH· Source
Recruiting
A Study in Pediatric Participants With Congenital Adrenal Hyperplasia (Balance-CAH)
NCT07159841· Phase 2/3· Crinetics Pharmaceuticals Inc.· Source
Recruiting
Phase II, multicentre, randomised, open-label trial with MAP +/- denosumab regimen for the treatment of patients with metastatic osteosarcoma
2024-518167-35-01· Phase 2· Associazione Italiana Ematologia Oncologia Pediatrica· Source
Recruiting
Study on chemotherapy and experimental drugs in patients with Philadelphia Chromosome positive and ABL-class Philadelphia Chromosome-Like B-cell Acute Lymphoblastic Leukemia
2025-520982-39-00· Phase 3· Universita Degli Studi Di Milano Bicocca· Source
Active, not recruiting
A Study of Subcutaneous Blinatumomab in Children With R/R and and MRD+ B-Cell Precursor Acute Lymphoblastic Leukemia
NCT07134088· Phase 1/2· Amgen· Source
Active, not recruiting
An Extension Study Evaluating 6-week Treatment Cycles of Rozanolixizumab in Pediatric Study Participants With Generalized Myasthenia Gravis
NCT06540144· Phase 3· UCB Biopharma SRL· Source
Recruiting
AZD0486 as Monotherapy in B-cell Acute Lymphoblastic Leukaemia
NCT06137118· Phase 1/2· AstraZeneca· Source
Not yet recruiting
Phase II Prospective Multicenter Study of High-Dose Treosulfan/Melphalan as Consolidation Treatment in Newly Diagnosed High-Risk and Very High-Risk Ewing Sarcoma
2024-518912-37-01· Phase 2· Fondazione Santobono Pausilipon Onlus· Source
Recruiting
A Study to Learn More About the Study Medicine Called Inotuzumab Ozogamicin (InO) in Children (1 to <18 Years) With First Relapse ALL
NCT05748171· Phase 2· Pfizer· Source
Active, not recruiting
DAY101 vs. Standard of Care Chemotherapy in Pediatric Participants With Low-Grade Glioma Requiring First-Line Systemic Therapy (LOGGIC/FIREFLY-2)
NCT05566795· Phase 3· Day One Biopharmaceuticals, Inc.· Source
Recruiting
SIOP-HRMB: An international prospective trial on clinically high-risk medulloblastoma (HR-MB) in patients older than 3 years.
2024-510578-25-00· Phase 3· The University Of Birmingham· Source
Recruiting
Observational Study on Skeletal Ewing's Sarcoma
NCT04845893· Italian Sarcoma Group· Source
Contact: Massimo Eraldo Abate, MD
Recruiting
FaR-RMS: An Overarching Study for Children and Adults With Frontline and Relapsed RhabdoMyoSarcoma
NCT04625907· Phase 1/2· University of Birmingham· Source
Recruiting
An international trial for children with atypical teratoid/rhabdoid tumours (ATRT)
2022-501456-28-00· Phase 3· GPOH gGmbH· Source
Recruiting
High-Risk Neuroblastoma Study 2 of SIOP-Europa-Neuroblastoma (SIOPEN)
NCT04221035· Phase 3· Gustave Roussy, Cancer Campus, Grand Paris· Source
Recruiting
Treatment Study for Children and Adolescents With Acute Promyelocytic Leukemia
NCT04793919· Phase 2· Associazione Italiana Ematologia Oncologia Pediatrica· Source
Recruiting
International Study for Treatment of High Risk Childhood Relapsed ALL 2010
NCT03590171· Phase 2· Charite University, Berlin, Germany· Source
Active, not recruiting
Imatinib Mesylate and Combination Chemotherapy in Treating Patients With Newly Diagnosed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia
NCT03007147· Phase 3· Children's Oncology Group· Source
Recruiting
SIOP Ependymoma II: An International Clinical Program for the diagnosis and treatment of children, adolescents and young adults with ependymoma
NCT02265770· Phase 2/3· Centre Leon Berard· Source
Recruiting
rEECur: International Randomised Controlled Trial of Chemotherapy for the Treatment of Recurrent and Primary Refractory Ewing Sarcoma
2024-516078-31-00· Phase 2/3· The University Of Birmingham· Source
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
Report an error